Nursing-Led Deep Vein Thrombosis Prevention in Neurosurgery
NCT ID: NCT07330661
Last Updated: 2026-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1286 participants
INTERVENTIONAL
2021-01-01
2024-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Main questions it aims to answer:
* Does the program lower the number of clots within 30 days after surgery?
* Is the program safer and more accurate than the usual clot-risk score nurses already use?
Researchers will compare patients who receive the nurse-led program with patients who receive standard hospital care.
Participants will:
* Be randomly assigned to one of the two groups.
* Have regular leg ultrasounds to check for clots.
* Wear a small activity tracker if they are in the nurse-led group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
This Research Proposal Focuses on Evaluating the Effectiveness of a Nursing Care Protocol in Preventing Deep Vein Thrombosis (DVT) in Patients Undergoing On-pump Cardiac Surgery. The Study Will Include an Intervention Group That Receives the Nursing Protocol and a Control Group That Receives Routine
NCT07347652
Application of IPC During Surgery to Prevent Venous Thrombosis in Gastrointestinal Surgery Patients.
NCT06260150
Prone Positioning in ARDS: Predicting Neurological Complications Via Cerebral Hemodynamics
NCT06967285
Assessment of Patient Positioning
NCT02532582
PWV for Cardiovascular Complication After Cardiac Surgery
NCT02014012
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nurse-led prevention group
In addition to routine post-operative care, participants assigned to the nurse-led prevention arm receive:
* Graded early-movement plan starting within 24 h of surgery
* Unconscious patients: passive leg exercises 10-15 min, 3× daily
* Conscious patients: assisted leg, sitting and walking sessions escalated daily (target ≥ 40 min total activity, logged automatically by a wrist-band activity tracker)
* Intermittent pneumatic compression (IPC)
* 2 h/session, 2× daily, 30-45 mmHg while in bed, continued until independent walking
* D-dimer blood checks on post-op days 1, 3, 7 and 14; any rise ≥ 20 % or level \> 2 mg/L triggers an extra leg ultrasound
* Continuous safety watch (heart rate, blood pressure, intracranial pressure if monitored); IPC or movement is paused if pressure \> 20 mmHg or vital signs become unstable
All steps are recorded in the electronic nursing chart and coordinated by a neurosurgery-rehabilitation-data
nurse-led program (early movement, leg-sleeve squeezes, and blood tests)
Graded early-movement plan starting within 24 h of surgery
* Unconscious patients: passive leg exercises 10-15 min, 3× daily
* Conscious patients: assisted leg, sitting and walking sessions escalated daily (target ≥ 40 min total activity, logged automatically by a wrist-band activity tracker) Intermittent pneumatic compression (IPC)
* 2 h/session, 2× daily, 30-45 mmHg while in bed, continued until independent walking D-dimer blood checks on post-op days 1, 3, 7 and 14; any rise ≥ 20 % or level \> 2 mg/L triggers an extra leg ultrasound Continuous safety watch (heart rate, blood pressure, intracranial pressure if monitored); IPC or movement is paused if pressure \> 20 mmHg or vital signs become unstable
Standard post-neurosurgical care group
Participants in the control arm receive the hospital's standard post-neurosurgical care, which follows current Chinese and U.S. VTE-guidelines and includes:
* Routine hydration and general health-education advice
* Graduated compression stockings (class II, knee-high) worn 8-12 h each day until the patient is walking independently
* Gentle passive leg movements (about 10 min, 1-2 times daily) when nursing staff judge it safe
* Low-molecular-weight heparin (40 mg enoxaparin subcutaneous once daily) only for patients judged to be at low bleeding risk (Caprini 4-7) and with no intracranial hemorrhage
No systematic Caprini re-assessments, no scheduled early-mobilization protocol, no IPC machines, no D-dimer surveillance, and no activity trackers are used.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
nurse-led program (early movement, leg-sleeve squeezes, and blood tests)
Graded early-movement plan starting within 24 h of surgery
* Unconscious patients: passive leg exercises 10-15 min, 3× daily
* Conscious patients: assisted leg, sitting and walking sessions escalated daily (target ≥ 40 min total activity, logged automatically by a wrist-band activity tracker) Intermittent pneumatic compression (IPC)
* 2 h/session, 2× daily, 30-45 mmHg while in bed, continued until independent walking D-dimer blood checks on post-op days 1, 3, 7 and 14; any rise ≥ 20 % or level \> 2 mg/L triggers an extra leg ultrasound Continuous safety watch (heart rate, blood pressure, intracranial pressure if monitored); IPC or movement is paused if pressure \> 20 mmHg or vital signs become unstable
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Any elective or emergency craniotomy, spinal, or other neurosurgical procedure
* Expected post-operative hospital stay ≥ 3 days
* Patient or legally authorized representative willing and able to give written informed consent
Exclusion Criteria
* Known hereditary bleeding disorder (e.g., hemophilia) or platelet count \< 50 × 10⁹/L
* Chronic therapeutic anticoagulation (warfarin, DOAC, heparin) that cannot be safely stopped, or need for full-dose post-op anticoagulation
* Severe liver disease (Child-Pugh class C) or eGFR \< 30 mL/min/1.73 m²
* Life-limiting co-morbidity with expected survival \< 30 days
* Pregnancy or breastfeeding
* Current participation in another interventional VTE trial
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
West China Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhigang Lan
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
West China Hospital of Sichuan University
Chengdu, Sichuan, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WestChinaH-HX-2025-010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.